Hints and tips:
...US medical device maker Stryker will buy smaller rival Wright Medical in a deal worth $5.4bn including debt as it seeks to boost its exposure to the fast-growing orthopaedics market....
...short order, Mr Nawana has overhauled much of the FTSE 100 company’s executive leadership and begun to discuss using dealmaking as a way to grow in businesses adjacent to its existing product lines in orthopaedic...
...Medical devices, however, declined 4.8 per cent to $5.9bn as elective and non-essential procedures relating to surgery, orthopaedics and other fields were pushed back to free up healthcare service capacity...
...Twelve times 2021 ev/ebitda looks cheap versus 13.5 times for Zimmer and Stryker, they say: We are upgrading SN to Overweight as we believe the fundamentals of the business are less challenged compared...
...Besides Stryker, other leaders in the industry include Johnson & Johnson, which acquired orthopaedic device maker Synthes for $21.3bn in 2012, and Zimmer Biomet, which was formed by a $14bn takeover in 2014...
...He has installed presidents for each division — sports medicine; orthopaedics and wound management — in an attempt to sharpen execution in a sector marked by constant evolution....
...Putting the orthopaedic devices or wound management businesses up for sale would likely attract interest from both industry buyers and private equity, while rivals including Stryker would likely want the...
...Actually, maybe add the orthopaedic cost from hauling said rucksack around too? Not that Tesla hasn't been at this sort of thing before....
...Stryker, which in 2014 disclosed that it had been working on a bid, was once again being mooted by day traders as a potential buyer....
...“[G]iven the consolidated and highly regulated nature of the mature orthopaedic space, we continue to see Stryker and (lesser so) Medtronic as the best suitors — not just from the regulatory angle (either...
...Stryker, the US device maker which four years ago disclosed it had been considering a bid for Smith & Nephew, has seen its own share price rise more than 20 per cent in the past year, for example....
...US rivals Stryker and Johnson & Johnson both have the capacity to bid....
...Stryker trades at 22 times forward earnings. Intuitive Surgical at 39 times. Both, however, are valued far below technology company multiples and are already profitable....
...On the same day, US medical device group Stryker also unveiled a $2.8bn deal to buy Sage, which makes products to prevent infections in hospitals....
...But S&N shares pared losses after Stryker management said on a post-acquisition conference call that the company “still has capacity to do more deals”, and flagged up orthopaedics as an area of interest....
...The company has been the subject of takeover speculation involving Stryker, a Fortune 500 medical technologies company based in Kalamazoo in Michigan....
...Also on Monday, medical device company Stryker agreed to buy Sage, which makes care products, for $2.8bn....
...The rally in risk assets has provided an opening for the sale of new debt, with Berkshire Hathaway, ConocoPhillips, Stryker, Citigroup and a subsidiary of Nissan Motor completing multibillion-dollar deals...
...For all the talk of diversification, much still depends on S&N’s ability to compete in orthopaedics....
...Shares in Stryker , the medical device company, fell earlier in the day after it announced a deal to buy Sage Products, which makes care products, for $2.78bn. They closed almost flat....
...Smith & Nephew says it has proved it can prosper in the shadow of bigger rivals such as Johnson & Johnson and Stryker and stands to benefit from upheaval among its competitors....
...The cuts equate to roughly 6 per cent of the company’s medical devices workforce, and will be heaviest in the orthopaedics division, which makes hip replacements, as well as its surgical and cardiovascular...
...A number of clinician-led clinics are also growing, such as one by Fortius, a specialist in orthopaedic and sports injuries....
...Sector peer Stryker last year examined a bid for S&N but was said to have paused the process awaiting regulatory clearance of Zimmer’s merger....
...The recession has made life even tougher for the family, says Mr Mendes Machado, who earns a commission from selling orthopaedic mattresses....
International Edition